Conor McNamara
Stock Analyst at RBC Capital
(0.82)
# 3,798
Out of 5,182 analysts
128
Total ratings
27.45%
Success rate
-14.52%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $48.36 | +50.95% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $4.85 | +3.09% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $194.24 | +31.28% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.66 | +80.72% | 4 | Aug 7, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $8.31 | +104.57% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $141.88 | -11.19% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $254.32 | +60.82% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $255.54 | +60.05% | 14 | Aug 1, 2025 | |
| RGEN Repligen | Maintains: Outperform | $193 → $204 | $123.46 | +65.24% | 12 | Jul 30, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $465.00 | +36.99% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $171.16 | +46.06% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $10.80 | +464.81% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $5.15 | +35.92% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $48.36
Upside: +50.95%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $4.85
Upside: +3.09%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $194.24
Upside: +31.28%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.66
Upside: +80.72%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.31
Upside: +104.57%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $141.88
Upside: -11.19%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $254.32
Upside: +60.82%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $255.54
Upside: +60.05%
Repligen
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $123.46
Upside: +65.24%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $465.00
Upside: +36.99%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $171.16
Upside: +46.06%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $10.80
Upside: +464.81%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $5.15
Upside: +35.92%